Abstract
IntroductionWidespread misperceptions of the health risks of nicotine could undermine the public health benefits of the Food and Drug Administration’s actions, including modified risk tobacco product authorisations and a reduced nicotine product standard for cigarettes.Methods794 US adults (aged 18+) in NORC’s AmeriSpeak panel participated in a randomised controlled trial in Spring 2021 to test the effect of three exposures to eight nicotine corrective messages (NCM) on beliefs about nicotine, nicotine replacement therapy (NRT), e-cigarettes and reduced nicotine content (RNC) cigarettes at 3-month follow-up. Analyses conducted in 2022 examined the effect of study condition (NCM (n=393) vs no message control (n=401)) on nicotine beliefs, use intentions and use of nicotine and tobacco products.ResultsExposure to three NCM doses reduced nicotine (b=−0.33; 95% CI −0.60, –0.07), NRT (b=−0.49; 95% CI −0.85, –0.14), e-cigarette (b=−0.32; 95% CI −0.59, –0.05) and RNC cigarette false beliefs (b=−0.64; 95% CI −1.26, –0.02) compared with the control, controlling for baseline beliefs. Baseline tobacco use and concern about nicotine addiction attenuated intervention effects on false beliefs about RNC cigarettes. There were few intervention effects on intention or use of nicotine and tobacco products.ConclusionsRepeated exposure to NCM was necessary to reduce false beliefs about nicotine and tobacco products. Future studies will improve understanding of the dose and duration of nicotine education needed to shift intentions and behaviour, as well as tailored content for tobacco product users to achieve similar reductions in false beliefs as non-users.Trial registration numberNCT04805515.
Funder
National Institute on Drug Abuse of the National Institutes of Health
National Institutes of Health
Subject
Public Health, Environmental and Occupational Health,Health (social science)
Reference45 articles.
1. U.S. Food and Drug Administration . FDA’s comprehensive plan for tobacco and nicotine regulation. 2017. Available: https://www.fda.gov/TobaccoProducts/NewsEvents/ucm568425.htm
2. U.S. Food and Drug Administration . FDA announces plans for proposed rule to reduce addictiveness of cigarettes and other combusted tobacco products. 2022 Available: https://www.fda.gov/news-events/press-announcements/fda-announces-plans-proposed-rule-reduce-addictiveness-cigarettes-and-other-combusted-tobacco
3. U.S. adults' addiction and harm beliefs about nicotine and low nicotine cigarettes;O’Brien;Prev Med,2017
4. Public misperception that very low nicotine cigarettes are less carcinogenic
5. Prevalence and correlates of nicotine and nicotine product perceptions in U.S. young adults, 2016;Villanti;Addictive Behaviors,2019